Literature DB >> 32149488

Unusual case report of skin infection by Paenibacillus timonensis.

A de Salazar1, F Ferrer, D Vinuesa, N Chueca, C de Luis-Perez, F García.   

Abstract

Entities:  

Keywords:  16S rRNA; MALDI-TOF; Paenibacillus spp.; Paenibacillus timonensis

Mesh:

Year:  2020        PMID: 32149488      PMCID: PMC7111240          DOI: 10.37201/req/079.2019

Source DB:  PubMed          Journal:  Rev Esp Quimioter        ISSN: 0214-3429            Impact factor:   1.553


× No keyword cloud information.
Sir, Paenibacillus is a genus of gram-positive bacilli endospore forming aerobic or facultatively anaerobic bacteria, that were originally included in the genus Bacillus [1, 2]. These bacteria are well adapted to the environment, and have been isolated from various sources including water, soil, food and plants, but they are not usually associated with infection. In the last decades, reports of infection in humans has increased through the years, and has been isolated mostly from wound exudates, and others from mitral endocarditis, bone infection and bacteremias [3-6]. Due to its widespread distribution when Paenibacillus is isolated, it is important to discriminate infection from contamination; in this context repeated isolation form multiple samples may indicate clinical significance. Here we report, to our knowledge, the first case of soft tissue and skin infection by Paenibacillus timonensis, and we describe the second case of human infection by this species [7]. A 37-year-old man with a medical history of arterial hypertension and neurofibromatosis type 1, also known as von Recklinghausen’s disease, was admitted to the emergency room of our university hospital for treatment of a severe pain and swelling in lower left limb due to strong trauma on May 2019. He was operated urgently due to a compartment syndrome in the left knee. After leaving the operating room, he presented serous secretion at one of the points of the scar, sending deep samples for culture to the microbiology laboratory. After 24 hours of incubation, greyish, translucent and shiny colonies grew in pure culture in aerobic blood agar (BD Columbia Agar 5% Sheepblood®, Becton Dickinson) and chocolate agar in a 5% CO2 atmosphere (BD Choco Agar, Becton Dickinson). Catalase test was positive and oxidase was negative. Gram strain revealed Gram-positive rod-shaped bacteria. Identification was performed using MALDI-TOF MS (Bruker Biotyper, MA, USA), with the result of P. timonensis with best-match score values of 1.96. Considering that a minimum score of 2 for species determination, the identification was confirmed by the partial sequencing (949 bp) of the 16S rRNA gene using universal primers. This isolate shared 99.88% sequence similarity with the reference sequence of P. timonensis available in GeneBank (KT719432.1). Susceptibility testing (Minimun Inhibitory Concentration) was carried out by the E-test method in Mueller Hinton 5% Blood Agar (Becton Dickinson) incubated in aerobiosis at 37°C with readings after 24 and 48 hours. As no specific clinical breakpoints have been established for Paenibacillus, we used the EUCAST PK/PD (non-species related) clinical breakpoints. P. timonensis was susceptible to trimethoprim-sulfamethoxazole (<0.02 mg/L), gentamicin (0.094 mg/L), erythromycin (0.5 mg/L), cefotaxime (0.064 mg/L), rifampicin (0.125 mg/L), vancomycin (0.25 mg/L), and resistant to ampicilin (>32 mg/L). To rule out the presence of P. timonensis as a possible contaminant, we asked for new samples from the wound, that were sent during the next week. P. timonensis was isolated in 4 subsequent samples, thus considering it the cause of the infection. According to susceptibility testing results and the literature [8], the patient was treated with vancomycin intravenously (1 g/12h) for 10 days, followed by 3 weeks of trimethoprim/ sulfamethoxazole orally. Antibiotic treatment was accompanied with the use of negative pressure wound therapy with the use of portable device (PICOTM), that has been shown to optimize patient outpatient care and promote rapid wound healing [9, 10]. The patient presented a good evolution of the wound and continued to perform local cures every 7 days until full recovery. In summary, the genus Paenibacillus is an unusual cause of surgical wound infection. Within this group, P. timonensis had never been described as a pathogen in this clinical scenario. In our patient, rapid identification of the etiologic agent allowed quick initiation of antimicrobial treatment. We believe that subsequent isolation of P. timonensis in the following samples and clinical improvement after antibiotic treatment helped to show its clinical significance and to discriminate from a possible contamination.
  10 in total

1.  Severe Sepsis Secondary to Persistent Lysinibacillus sphaericus, Lysinibacillus fusiformis and Paenibacillus amylolyticus Bacteremia.

Authors:  Eric Wenzler; Kamal Kamboj; Joan-Miquel Balada-Llasat
Journal:  Int J Infect Dis       Date:  2015-04-27       Impact factor: 3.623

2.  Breast implant infection due to Paenibacillus residui in a cancer patient.

Authors:  A Marchese; R Barbieri; M Pesce; S Franchelli; A De Maria
Journal:  Clin Microbiol Infect       Date:  2016-05-27       Impact factor: 8.067

3.  Intraoperative diagnosis of mitral valve endocarditis secondary to Paenibacillus provencensis.

Authors:  A-C Pinho-Gomes; A Nasir; R Mosca; S Mirza; I Kadir
Journal:  Ann R Coll Surg Engl       Date:  2016-10-28       Impact factor: 1.891

4.  Paenibacillus massiliensis sp. nov., Paenibacillus sanguinis sp. nov. and Paenibacillus timonensis sp. nov., isolated from blood cultures.

Authors:  Véronique Roux; Didier Raoult
Journal:  Int J Syst Evol Microbiol       Date:  2004-07       Impact factor: 2.747

Review 5.  What is the effectiveness of the negative pressure wound therapy (NPWT) in patients treated with open abdomen technique? A systematic review and meta-analysis.

Authors:  Roberto Cirocchi; Arianna Birindelli; Walter L Biffl; Ventsislav Mutafchiyski; Georgi Popivanov; Osvaldo Chiara; Gregorio Tugnoli; Salomone Di Saverio
Journal:  J Trauma Acute Care Surg       Date:  2016-09       Impact factor: 3.313

6.  In vitro susceptibility of Bacillus spp. to selected antimicrobial agents.

Authors:  D J Weber; S M Saviteer; W A Rutala; C A Thomann
Journal:  Antimicrob Agents Chemother       Date:  1988-05       Impact factor: 5.191

Review 7.  Current knowledge and perspectives of Paenibacillus: a review.

Authors:  Elliot Nicholas Grady; Jacqueline MacDonald; Linda Liu; Alex Richman; Ze-Chun Yuan
Journal:  Microb Cell Fact       Date:  2016-12-01       Impact factor: 5.328

8.  Paenibacillus spp. isolated from human and environmental samples in Spain: detection of 11 new species.

Authors:  J A Sáez-Nieto; M J Medina-Pascual; G Carrasco; N Garrido; M A Fernandez-Torres; P Villalón; S Valdezate
Journal:  New Microbes New Infect       Date:  2017-05-24

9.  Application of the Single Use Negative Pressure Wound Therapy Device (PICO) on a Heterogeneous Group of Surgical and Traumatic Wounds.

Authors:  Caroline Payne; Daren Edwards
Journal:  Eplasty       Date:  2014-04-28

10.  First case of bone infection caused by Paenibacillus turicensis.

Authors:  F Quénard; C Aubry; M Palmieri; S Edouard; P Parola; J-C Lagier
Journal:  New Microbes New Infect       Date:  2016-02-23
  10 in total
  1 in total

Review 1.  Paenibacillus amylolyticus osteomyelitis in a Poodle dog: case report and literature review.

Authors:  Elisa Rampacci; Monica Sforna; Alfredo Dentini; Irene Di Matteo; Plinio Lidano; Cristiana Capucci; Fabrizio Passamonti
Journal:  J Vet Diagn Invest       Date:  2022-06-07       Impact factor: 1.569

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.